|
by Peprah, Kwakye, Argáez, Charlene
Published 2017
“... for the use of Dialectical Behavioral Therapy (DBT) in the treatment of adult patients with mental illness...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, Argáez, Charlene
Published 2017
“... for the use of Dialectical Behavioral Therapy (DBT) in the treatment of adult patients with mental illness...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Jahagirdar, Deepa, Kaunelis, David
Published 2017
Subjects:
“...Mentally Ill Persons...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Jahagirdar, Deepa, Kaunelis, David
Published 2017
Subjects:
“...Mentally Ill Persons...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Williams, D., Mierzwinski-Urban, Monika
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Williams, D., Mierzwinski-Urban, Monika
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Chao, Yi-Sheng, Spry, Carolyn
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Chao, Yi-Sheng, Spry, Carolyn
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Yeung, Shirley S. T., Loshak, Hannah
Published 2019
Subjects:
“...Critical Illness...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Picheca, Lory
Published 2017
Subjects:
“...Severity of Illness Index...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Picheca, Lory
Published 2017
Subjects:
“...Severity of Illness Index...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by MacDonald, Erika, McCormack, Suzanne
Published 2020
“... of ondansetron for pediatric patients with or at risk of mild to moderate dehydration. For the purposes...”Published 2020
Canadian Agency for Drugs and Technologies in Health